Literature DB >> 22079347

Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1.

Cindy Achat-Mendes1, Laurie J Lynch, Katherine A Sullivan, Eric J Vallender, Gregory M Miller.   

Abstract

The trace amine-associated receptor 1 (TAAR1) is a G protein-coupled receptor that is functionally activated by amphetamine-based psychostimulants, including amphetamine, methamphetamine and MDMA. Previous studies have shown that in transgenic mice lacking the TAAR1 gene (TAAR1 knockout; KO) a single injection of amphetamine can produce enhanced behavioral responses compared to responses evoked in wild-type (WT) mice. Further, the psychostimulant effects of cocaine can be diminished by selective activation of TAAR1. These findings suggest that TAAR1 might be implicated in the rewarding properties of psychostimulants. To investigate the role of TAAR1 in the rewarding effects of drugs of abuse, the psychomotor stimulating effects of amphetamine and methamphetamine and the conditioned rewarding effects of methamphetamine and morphine were compared between WT and TAAR1 KO mice. In locomotor activity studies, both single and repeated exposure to d-amphetamine or methamphetamine generated significantly higher levels of total distance traveled in TAAR1 KO mice compared to WT mice. In conditioned place preference (CPP) studies, TAAR1 KO mice acquired methamphetamine-induced CPP earlier than WT mice and retained CPP longer during extinction training. In morphine-induced CPP, both WT and KO genotypes displayed similar levels of CPP. Results from locomotor activity studies suggest that TAAR1 may have a modulatory role in the behavioral sensitization to amphetamine-based psychostimulants. That methamphetamine-but not morphine-induced CPP was augmented in TAAR1 KO mice suggests a selective role of TAAR1 in the conditioned reinforcing effects of methamphetamine. Collectively, these findings provide support for a regulatory role of TAAR1 in methamphetamine signaling. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079347      PMCID: PMC3288391          DOI: 10.1016/j.pbb.2011.10.025

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  32 in total

1.  Methamphetamine-induced conditioned place preference or aversion depending on dose and presence of drug.

Authors:  C L Cunningham; D Noble
Journal:  Ann N Y Acad Sci       Date:  1992-06-28       Impact factor: 5.691

2.  Morphine reward in dopamine-deficient mice.

Authors:  Thomas S Hnasko; Bethany N Sotak; Richard D Palmiter
Journal:  Nature       Date:  2005-12-08       Impact factor: 49.962

3.  The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia.

Authors:  T D Wolinsky; C J Swanson; K E Smith; H Zhong; B Borowsky; P Seeman; T Branchek; C P Gerald
Journal:  Genes Brain Behav       Date:  2006-12-21       Impact factor: 3.449

4.  Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine.

Authors:  E A Reese; J R Bunzow; S Arttamangkul; M S Sonders; D K Grandy
Journal:  J Pharmacol Exp Ther       Date:  2007-01-11       Impact factor: 4.030

5.  Amphetamine-induced place preference and conditioned motor sensitization requires activation of tyrosine kinase receptors in the hippocampus.

Authors:  Fei Shen; Gloria E Meredith; T Celeste Napier
Journal:  J Neurosci       Date:  2006-10-25       Impact factor: 6.167

6.  Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice.

Authors:  Cindy Achat-Mendes; Syed F Ali; Yossef Itzhak
Journal:  Neuropsychopharmacology       Date:  2005-06       Impact factor: 7.853

7.  Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro.

Authors:  Zhihua Xie; Susan V Westmoreland; Mary E Bahn; Guo-Lin Chen; Hong Yang; Eric J Vallender; Wei-Dong Yao; Bertha K Madras; Gregory M Miller
Journal:  J Pharmacol Exp Ther       Date:  2007-01-18       Impact factor: 4.030

8.  beta-Phenylethylamine and reinforcement.

Authors:  A J Greenshaw
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1984       Impact factor: 5.067

9.  Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.

Authors:  Zhihua Xie; Gregory M Miller
Journal:  J Pharmacol Exp Ther       Date:  2008-01-08       Impact factor: 4.030

10.  Trace amine-associated receptor 1 modulates dopaminergic activity.

Authors:  Lothar Lindemann; Claas Aiko Meyer; Karine Jeanneau; Amyaouch Bradaia; Laurence Ozmen; Horst Bluethmann; Bernhard Bettler; Joseph G Wettstein; Edilio Borroni; Jean-Luc Moreau; Marius C Hoener
Journal:  J Pharmacol Exp Ther       Date:  2007-12-14       Impact factor: 4.030

View more
  38 in total

1.  Avenues for the development of therapeutics that target trace amine associated receptor 1 (TAAR1).

Authors:  Gregory M Miller
Journal:  J Med Chem       Date:  2012-01-20       Impact factor: 7.446

2.  The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats.

Authors:  David A Thorn; Chaogui Zhang; Yanan Zhang; Jun-Xu Li
Journal:  Neurosci Lett       Date:  2014-02-21       Impact factor: 3.046

3.  Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity.

Authors:  Nicholas B Miner; Josh S Elmore; Michael H Baumann; Tamara J Phillips; Aaron Janowsky
Journal:  Neurotoxicology       Date:  2017-09-15       Impact factor: 4.294

Review 4.  TAAR Agonists.

Authors:  Zhengrong Xu; Qian Li
Journal:  Cell Mol Neurobiol       Date:  2019-12-17       Impact factor: 5.046

Review 5.  Commonalities and Distinctions Among Mechanisms of Addiction to Alcohol and Other Drugs.

Authors:  Angela R Ozburn; Aaron J Janowsky; John C Crabbe
Journal:  Alcohol Clin Exp Res       Date:  2015-10       Impact factor: 3.455

6.  TAAR1 Modulates Cortical Glutamate NMDA Receptor Function.

Authors:  Stefano Espinoza; Gabriele Lignani; Lucia Caffino; Silvia Maggi; Ilya Sukhanov; Damiana Leo; Liudmila Mus; Marco Emanuele; Giuseppe Ronzitti; Anja Harmeier; Lucian Medrihan; Tatyana D Sotnikova; Evelina Chieregatti; Marius C Hoener; Fabio Benfenati; Valter Tucci; Fabio Fumagalli; Raul R Gainetdinov
Journal:  Neuropsychopharmacology       Date:  2015-03-09       Impact factor: 7.853

7.  Trace Amine-Associated Receptor 1 Regulation of Methamphetamine Intake and Related Traits.

Authors:  John H Harkness; Xiao Shi; Aaron Janowsky; Tamara J Phillips
Journal:  Neuropsychopharmacology       Date:  2015-03-05       Impact factor: 7.853

Review 8.  TAAR1 and Psychostimulant Addiction.

Authors:  Jianfeng Liu; Ruyan Wu; Jun-Xu Li
Journal:  Cell Mol Neurobiol       Date:  2020-01-23       Impact factor: 5.046

9.  TAAR1 agonists attenuate extended-access cocaine self-administration and yohimbine-induced reinstatement of cocaine-seeking.

Authors:  Jianfeng Liu; Bernard Johnson; Ruyan Wu; Robert Seaman; Jimmy Vu; Qing Zhu; Yanan Zhang; Jun-Xu Li
Journal:  Br J Pharmacol       Date:  2020-05-05       Impact factor: 8.739

10.  Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats.

Authors:  David A Thorn; Li Jing; Yanyan Qiu; Amy M Gancarz-Kausch; Chad M Galuska; David M Dietz; Yanan Zhang; Jun-Xu Li
Journal:  Neuropsychopharmacology       Date:  2014-04-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.